Attaya Suvannasankha Selected Research

Attaya Suvannasankha Research Topics

Disease

20	Multiple Myeloma 05/2024 - 09/2006
12	Neoplasms (Cancer) 05/2024 - 10/2006
5	Breast Neoplasms (Breast Cancer) 12/2014 - 06/2002
3	Infections 07/2018 - 05/2003
3	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2014
2	Disease Progression 11/2021 - 01/2020
2	Plasmacytoma 06/2018 - 08/2010
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2006 - 05/2004
1	Residual Neoplasm 01/2023
1	Immunoglobulin Light-chain Amyloidosis 01/2019
1	Granuloma 12/2018
1	Autoimmune Diseases (Autoimmune Disease) 07/2018
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 07/2018
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 07/2018
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2018
1	Pain (Aches) 06/2018
1	Erythema 06/2018
1	Nervous System Diseases (Neurological Disorders) 01/2018
1	Neutropenia 01/2017
1	Adenocarcinoma 10/2015
1	Hypoxia (Hypoxemia) 12/2014
1	Osteoporosis 01/2014
1	Hematologic Neoplasms (Hematological Malignancy) 01/2014
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2006
1	Thrombocytopenia (Thrombopenia) 09/2006

Drug/Important Bio-Agent (IBA)

6	belantamab mafodotinIBA 04/2024 - 01/2020
4	Immunomodulating AgentsIBA 05/2024 - 01/2020
3	Proteasome InhibitorsIBA 11/2021 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 11/2004 - 06/2002
2	B-Cell Maturation AntigenIBA 01/2023 - 01/2020
2	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 01/2020
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2010 - 10/2006
1	pembrolizumabIBA 04/2024
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2023
1	Dihydrotachysterol (AT 10)IBA 01/2023
1	Bispecific AntibodiesIBA 01/2023
1	Monoclonal AntibodiesIBA 01/2020
1	Factor X (Stuart Factor)IBA 01/2019
1	Amyloidogenic ProteinsIBA 01/2019
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2019
1	AutoantibodiesIBA 07/2018
1	AgglutininsIBA 07/2018
1	CD100 antigenIBA 01/2018
1	daratumumabIBA 01/2017
1	pomalidomideIBA 01/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	Cell Adhesion MoleculesIBA 12/2016
1	Gemcitabine FDA Link 10/2015
1	heparanaseIBA 08/2015
1	infigratinibIBA 08/2015
1	Messenger RNA (mRNA)IBA 12/2014
1	AdrenomedullinIBA 12/2014
1	Peptides (Polypeptides)IBA 12/2014
1	Nuclear Proteins (Protein, Nuclear)IBA 09/2014
1	RNA Precursors (Precursor, mRNA)IBA 09/2014
1	Parathyroid Hormone (Parathormone)IBA 01/2014
1	AntibodiesIBA 01/2014
1	Estrogen ReceptorsIBA 01/2014
1	Everolimus FDA Link 01/2014
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2014
1	ACE-011IBA 01/2014
1	activin AIBA 01/2014
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2014
1	Anabolic AgentsIBA 01/2014
1	strontium ranelate (protelos)IBA 01/2014
1	TOR Serine-Threonine KinasesIBA 01/2014
1	LigandsIBA 11/2012
1	Immunoglobulins (Immunoglobulin)IBA 11/2012
1	IPH-2101IBA 11/2012
1	Death-Associated Protein KinasesIBA 01/2012
1	Histone Deacetylase InhibitorsIBA 07/2011
1	ENMD 2076IBA 08/2010
1	Aurora KinasesIBA 08/2010
1	NF-kappa B (NF-kB)IBA 03/2008
1	OSU 03012IBA 08/2007
1	Celecoxib (Celebrex)FDA Link 08/2007
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2007
1	Cytidine Triphosphate (CTP)IBA 01/2007
1	Prednisone (Sone)FDA LinkGeneric 01/2007
1	Thalidomide (Thalomid)FDA Link 01/2007
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2007
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 10/2006
1	fms-Like Tyrosine Kinase 3IBA 10/2006
1	JNK Mitogen-Activated Protein KinasesIBA 10/2006
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2006
1	Bortezomib (Velcade)FDA Link 09/2006
1	Methylprednisolone FDA LinkGeneric 09/2006
1	GlucocorticoidsIBA 09/2006
1	Core Binding Factors (Core-Binding Factor)IBA 05/2004
1	major vault proteinIBA 05/2004
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2004
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 05/2004
1	core binding factor alphaIBA 05/2004

Therapy/Procedure

7	Therapeutics 01/2023 - 07/2011
3	Drug Therapy (Chemotherapy) 07/2018 - 10/2015
1	Intravenous Infusions 01/2020
1	Liver Transplantation 12/2018
1	Orchiectomy (Orchidectomy) 06/2018
1	Stem Cell Transplantation 01/2014